insights_auto
Why is BOT down 6.67%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.014
arrow_downward
-6.67%(-0.00100) 1D
Oct 9, 4:10:30 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$0.02
High
A$0.02
Low
A$0.01
Mkt. cap
32.86M
Avg. vol.
6.53M
Volume
5.03M
52-wk high
A$0.17
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
Open
A$0.02
High
A$0.02
Low
A$0.01
Mkt. cap
32.86M
Avg. vol.
6.53M
Volume
5.03M
52-wk high
A$0.17
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
News stories
From web sources and news partners
Yahoo Finance UK
·
46 minutes ago
Quantisimo Corp., the Pure-Play Sovereign Quantum Vertical Platform “Root to Qubit” Formed by WISeQey and SEALSQ, Signs Definitive Business Combination Agreement with GigCapital8 Corp. to Become a Nasdaq-Listed Public Company
The Lufkin Daily News
·
1 hour ago
FILE PHOTO: Traders react to the Fed rate announcement on the floor of the NYSE in New York
dailyrecordnews.com
·
53 minutes ago
Asian shares are mixed and crude prices fall after an unsettled day on Wall St
Bloomberg.com
·
5 hours ago
Watch Nasdaq CEO Friedman on IPO Outlook
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd